Summary & Overview
HCPCS C9779: Endoscopic Submucosal Dissection, Including Mucosal Closure
HCPCS Level II code C9779 denotes endoscopic submucosal dissection (ESD), including the endoscopy or colonoscopy and mucosal closure when performed, a specialized endoscopic therapeutic procedure for removing superficial gastrointestinal lesions. Nationally, recognition of ESD codes matters as hospitals, ambulatory surgical centers, and payers adapt coverage and billing practices for advanced endoscopic services that can reduce need for open surgery and affect care pathways.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how C9779 is used in clinical and billing contexts, national policy and payment considerations, and common operational benchmarks for service lines that perform ESD. The publication summarizes payer coverage themes and highlights coding and site-of-service implications relevant to gastroenterology, surgical endoscopy, and hospital outpatient operations.
This resource provides clinicians, administrators, and revenue cycle staff with the clinical meaning of the code, typical sites of service, and the types of information to expect when evaluating coverage and reimbursement for ESD services. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code C9779 describes endoscopic submucosal dissection (ESD), including the associated endoscopy or colonoscopy and mucosal closure when performed. The code represents a procedural service that removes superficial gastrointestinal lesions via dissection within the submucosal layer.
-
Service type: Endoscopic therapeutic procedure (endoscopic submucosal dissection)
-
Typical site of service: Hospital outpatient department, ambulatory surgical center, or endoscopy suite
Clinical & Coding Specifications
Clinical Context
A 67-year-old patient with a history of chronic gastroesophageal reflux disease undergoes surveillance upper endoscopy after prior biopsy-proven large sessile gastric epithelial neoplasm suspicious for high-grade dysplasia. Diagnostic endoscopy demonstrates a 25 mm superficial mucosal neoplasm confined to the mucosa/submucosa without deep invasion on endoscopic imaging and narrow-band assessment. The gastroenterology team schedules an endoscopic submucosal dissection (ESD) performed under monitored anesthesia care in an endoscopy suite. The procedure includes endoscopic or colonoscopic access, submucosal injection, circumferential mucosal incision, submucosal dissection to remove the lesion en bloc, hemostasis of bleeding vessels, and mucosal defect closure with clips or suturing devices when performed. Specimens are retrieved for pathology. Post-procedure recovery includes observation for bleeding or perforation, instructions for nil per os and gradual diet advancement, and follow-up outpatient visit with pathology review. Typical sites of service are the hospital outpatient department or ambulatory endoscopy center. Typical patient scenario variants include a colon ESD for large laterally spreading colorectal lesions or ESD of superficial esophageal neoplasms for organ-preserving therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard reporting | Use as the default when no specific modifier is applicable. |